Moritz F. Hamann - Publications

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 16, 2025

Correction: Evaluating the impact of histological vs. nuclear grading on CPS + EG Score for HR + /HER2-early breast cancer.

Journal: Breast cancer research and treatment

Published: June 19, 2025

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.

Journal: The Lancet. Oncology

Published: June 11, 2025

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

Journal: ESMO open

Published: April 07, 2025

Real-world quality of life outcomes after prepectoral implant-based breast reconstruction with or without titanium-coated mesh (TiLOOP® Bra Pocket): A prospective cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 13, 2025

Evaluating the impact of histological vs. nuclear grading on CPS + EG Score for HR + /HER2-early breast cancer.

Journal: Breast cancer research and treatment

Published: November 01, 2024

Real-world data of perioperative complications in prepectoral implant-based breast reconstruction: a prospective cohort study.

Journal: Archives of gynecology and obstetrics

Published: August 29, 2024

An Artificial Intelligence Algorithm Integrated into the Clinical Workflow Can Ensure High Quality Acute Intracranial Hemorrhage CT Diagnostic.

Journal: Clinical neuroradiology

Published: May 23, 2024

Spectrum of firework injuries at a university eye clinic after the COVID-19 lockdown

Journal: Die Ophthalmologie

Published: May 19, 2023

Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level.

Journal: Breast care (Basel, Switzerland)

Published: July 26, 2021

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 17, 2020

Sentinel lymph node mapping with indocyanine green compared to blue dye tracer in gynecologic malignancies-A single center experience of 218 patients.

Journal: Journal of surgical oncology

Published: July 25, 2020